Skip to main content
SpringerLink
Log in

Coxibe oder NSAR: Was wird besser vertragen?

  • AKTUELLE MEDIZIN_KRITISCH GELESEN
  • Published:
MMW - Fortschritte der Medizin Aims and scope

Erhöhen Coxibe und nicht-steroidale Antirheumatika (NSAR) das Risiko vaskulärer Erkrankungen? Wie hoch ist bei den einzelnen Substanzen das Risiko gastrointestinaler Nebenwirkungen?

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  • Coxib and traditional NSAID Trialists´ (CNT) Collaboration Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomized trials. Lancet 2013; doi:10.1016/S0140-6736(13)60900-9

Download references

Author information

Authors and Affiliations

  1. http://www.springermedizin.de

    H. -C. Diener

Authors
  1. H. -C. Diener
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Diener, H.C. Coxibe oder NSAR: Was wird besser vertragen?. MMW - Fortschritte der Medizin 155, 35 (2013). https://doi.org/10.1007/s15006-013-2328-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15006-013-2328-4

Search

Navigation